Emmanuel Zuber

662 total citations
15 papers, 458 citations indexed

About

Emmanuel Zuber is a scholar working on Statistics and Probability, Economics and Econometrics and Oncology. According to data from OpenAlex, Emmanuel Zuber has authored 15 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Statistics and Probability, 6 papers in Economics and Econometrics and 5 papers in Oncology. Recurrent topics in Emmanuel Zuber's work include Statistical Methods in Clinical Trials (11 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Cancer Genomics and Diagnostics (4 papers). Emmanuel Zuber is often cited by papers focused on Statistical Methods in Clinical Trials (11 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Cancer Genomics and Diagnostics (4 papers). Emmanuel Zuber collaborates with scholars based in Switzerland, United States and Austria. Emmanuel Zuber's co-authors include Michael Branson, Frank Bretz, Paul Gallo, Werner Brannath, Martin Posch, C. Barone, S. Tjulandin, Johannes Bükki, Christian Jacques and E. Van Cutsem and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Statistics in Medicine.

In The Last Decade

Emmanuel Zuber

14 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Zuber Switzerland 8 209 188 148 98 89 15 458
Elisa Rizzo Italy 6 132 0.6× 97 0.5× 190 1.3× 20 0.2× 39 0.4× 7 343
Melisa Tucker United States 9 301 1.4× 70 0.4× 357 2.4× 54 0.6× 86 1.0× 13 566
Melissa D. Curtis United States 6 217 1.0× 49 0.3× 258 1.7× 30 0.3× 68 0.8× 8 427
Agathe Guilloux France 9 138 0.7× 58 0.3× 309 2.1× 121 1.2× 15 0.2× 28 633
Kyung Mann Kim United States 10 38 0.2× 99 0.5× 102 0.7× 37 0.4× 31 0.3× 16 363
Brandon Arnieri United States 6 140 0.7× 117 0.6× 175 1.2× 44 0.4× 112 1.3× 10 498
Jiabu Ye United States 9 162 0.8× 51 0.3× 226 1.5× 31 0.3× 18 0.2× 19 339
Paul You United States 6 191 0.9× 44 0.2× 241 1.6× 34 0.3× 55 0.6× 8 412
Junshan Qiu United States 9 48 0.2× 134 0.7× 124 0.8× 12 0.1× 54 0.6× 22 422
Tie‐Hua Ng United States 8 32 0.2× 117 0.6× 35 0.2× 26 0.3× 38 0.4× 16 274

Countries citing papers authored by Emmanuel Zuber

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Zuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Zuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Zuber more than expected).

Fields of papers citing papers by Emmanuel Zuber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Zuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Zuber. The network helps show where Emmanuel Zuber may publish in the future.

Co-authorship network of co-authors of Emmanuel Zuber

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Zuber. A scholar is included among the top collaborators of Emmanuel Zuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Zuber. Emmanuel Zuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Degtyarev, Evgeny, Joshua Brody, Aby Buchbinder, et al.. (2024). End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?. Future Oncology. 20(22). 1601–1615. 1 indexed citations
2.
Izem, Rima, Emmanuel Zuber, Nadia Daizadeh, et al.. (2024). Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework. Therapeutic Innovation & Regulatory Science. 58(3). 495–504. 7 indexed citations
3.
Fleming, Thomas R., Lisa V. Hampson, Bharani Dharan, et al.. (2024). Monitoring Overall Survival in Pivotal Trials in Indolent Cancers. Statistics in Biopharmaceutical Research. 17(2). 161–172. 4 indexed citations
4.
Akacha, Mouna, Janice Branson, Frank Bretz, et al.. (2020). Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials. Statistics in Biopharmaceutical Research. 12(4). 419–426. 24 indexed citations
5.
Degtyarev, Evgeny, Yiyun Zhang, David Lebwohl, et al.. (2019). Estimands and the Patient Journey: Addressing the Right Question in Oncology Clinical Trials. JCO Precision Oncology. 3(3). 1–10. 14 indexed citations
6.
Akacha, Mouna, et al.. (2019). Estimands in a Chronic Pain Trial: Challenges and Opportunities. Statistics in Biopharmaceutical Research. 12(1). 39–44. 14 indexed citations
7.
Korhonen, Pasi, Emmanuel Zuber, Michael Branson, et al.. (2012). Correcting Overall Survival for the Impact of Crossover Via a Rank-Preserving Structural Failure Time (RPSFT) Model in the RECORD-1 Trial of Everolimus in Metastatic Renal-Cell Carcinoma. Journal of Biopharmaceutical Statistics. 22(6). 1258–1271. 28 indexed citations
8.
Neuenschwander, Beat, Nicolas Rouyrre, Norbert Hollaender, Emmanuel Zuber, & Michael Branson. (2011). A proof of concept phase II non‐inferiority criterion. Statistics in Medicine. 30(13). 1618–1627. 23 indexed citations
9.
Zuber, Emmanuel, Pasi Korhonen, Michael Branson, et al.. (2010). Correcting overall survival (OS) effect for the impact of cross-over via rank preserving structural failure time (RPSFT) model: Case of mRCC RECORD-1 trial of everolimus (EVE).. Journal of Clinical Oncology. 28(15_suppl). 4690–4690.
10.
11.
Brannath, Werner, Emmanuel Zuber, Michael Branson, et al.. (2009). Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology. Statistics in Medicine. 28(10). 1445–1463. 131 indexed citations
12.
13.
14.
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Rizzo Breakdown of academic impact, for papers by Melisa Tucker Breakdown of academic impact, for papers by Melissa D. Curtis Breakdown of academic impact, for papers by Agathe Guilloux Breakdown of academic impact, for papers by Kyung Mann Kim Breakdown of academic impact, for papers by Brandon Arnieri Breakdown of academic impact, for papers by Jiabu Ye Breakdown of academic impact, for papers by Paul You Breakdown of academic impact, for papers by Junshan Qiu Breakdown of academic impact, for papers by Tie‐Hua Ng
Rankless by CCL
2026